agonists in heart failure and chronic kidney disease (CKD) patients was discussed. GLP-1R agonists are cardioprotective in ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...

Ten hours or more of sedentary behaviour per day may increase heart failure risk even in those who regularly exercise, a new ...

Twin sisters living with heart failure are calling for an end to what they say is a postcode lottery when it comes to ...

Researchers have found a potential method to slow heart failure progression. They fed mice a diet high in soybean protein, which influenced gut bacteria and supported heart health. Analysis showed ...

Of the 518 hospitals that had at least 10 eligible discharges, only 11 of them prescribed SGLT2 inhibitors to more than half ...

A new study published in the Journal of the American College of Cardiology has found that being sedentary — by sitting, ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

Eli Lilly's tirzepatide cut cardiovascular mortality and heart failure event risk by 38% in HFpEF patients over a two-year ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...